Table 1.
Subject characteristics and sample sizes.
Feature | Cases | Controls |
---|---|---|
Swedish sample characteristics | ||
Male sex | 0.595 | 0.512 |
Median age at sampling | 54 (45-62) | 57 (48-65) |
Median hospital admissions for SCZ or SAD | 7 (3-15) | n/a |
Median total inpatient days | 243 (81-696) | n/a |
Median years from first to last HDR admission | 9.7 (2.9-19.5) | n/a |
Sample sizes | ||
Swedish subjects (Sw1-6) | 5,001 | 6,243 |
PGC schizophrenia subjects (excluding Sw1-2) | 8,832 | 12,067 |
Replication results for up to 168 genomic regions | 7,413 | 19,762 |
Total subjects | 21,246 | 38,072 |
Values in parentheses are inter-quartile ranges. The case group had significantly more males (p < 0.0001) and was significantly younger (p < 0.0001) than controls although these differences were not of large magnitude. The higher median age in controls is in the direction of greater confidence in control classification (i.e., controls had greater time at risk for psychiatric hospitalization). Cases tended to have had considerable hospitalizations, inpatient lengths of stay, and years of observation. IQQ=interquartile range, SCZ=schizophrenia, SAD=schizoaffective disorder, HDR=Hospital Discharge Register.
All cases and controls are independent. The Swedish sample totals N=11,244, the PGC N=20,899, and the replication samples N=27,175. The Sweden plus PGC meta-analysis is based on N=32, 143. The Swedish sample plus PGC plus replication samples total 59,318. (these counts exclude 511 trios).